---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-022237"
form_type: "8-K"
ticker: "CTXR"
cik: "0001506251"
company_name: "Citius Pharmaceuticals, Inc."
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T01:19:53.502645+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Citius shareholders defeat share-increase proposal, elect all director nominees

## Summary
- Proposal to raise authorized shares from 26M to 260M failed with 3,222,490 for vs. 1,934,414 against.
- All seven director nominees elected; Leonard Mazur received 2,301,986 for, 983,591 withheld.
- Advisory vote on executive compensation approved: 1,943,011 for, 1,196,649 against, 1,969,380 broker non-votes.
- Ratification of Wolf & Co. as auditor for FY2025 passed with 4,466,905 for, 592,161 against.

## SEC filing metadata
- accession: 0001213900-25-022237
- form_type: 8-K
- ticker: CTXR
- cik: 0001506251
- company_name: Citius Pharmaceuticals, Inc.
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506251/000121390025022237/0001213900-25-022237-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506251/000121390025022237/ea0233790-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-022237
- JSON: https://secwatch.observer/filing/0001213900-25-022237.json
- Plain text: https://secwatch.observer/filing/0001213900-25-022237.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.